Shares of Henry Schein, Inc. (NASDAQ:HSIC – Get Free Report) have been given a consensus rating of “Hold” by the eleven analysts that are covering the firm, Marketbeat reports. One investment analyst has rated the stock with a sell rating, five have assigned a hold rating and five have assigned a buy rating to the company. The average twelve-month price target among brokers that have issued ratings on the stock in the last year is $81.73.
Several analysts recently weighed in on the stock. Leerink Partnrs reaffirmed a “market perform” rating on shares of Henry Schein in a report on Monday, February 26th. TheStreet upgraded Henry Schein from a “c+” rating to a “b-” rating in a research note on Monday, February 26th. SVB Leerink began coverage on Henry Schein in a research report on Monday, February 26th. They set a “market perform” rating and a $78.00 price objective for the company. Piper Sandler reissued an “overweight” rating and set a $86.00 target price on shares of Henry Schein in a research report on Friday. Finally, Evercore ISI upped their price target on Henry Schein from $79.00 to $83.00 and gave the company an “in-line” rating in a report on Wednesday, February 28th.
Check Out Our Latest Stock Report on HSIC
Institutional Inflows and Outflows
Henry Schein Trading Up 0.0 %
Shares of NASDAQ HSIC opened at $67.27 on Tuesday. The stock has a fifty day simple moving average of $70.37 and a 200-day simple moving average of $73.10. Henry Schein has a twelve month low of $60.01 and a twelve month high of $82.63. The company has a current ratio of 1.75, a quick ratio of 1.02 and a debt-to-equity ratio of 0.47. The stock has a market capitalization of $8.61 billion, a PE ratio of 22.73, a PEG ratio of 1.64 and a beta of 0.90.
Henry Schein (NASDAQ:HSIC – Get Free Report) last issued its quarterly earnings results on Tuesday, May 7th. The company reported $1.10 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.01 by $0.09. Henry Schein had a net margin of 3.12% and a return on equity of 13.51%. The business had revenue of $3.17 billion for the quarter, compared to analysts’ expectations of $3.21 billion. During the same quarter in the prior year, the company earned $1.21 earnings per share. The business’s quarterly revenue was up 3.7% on a year-over-year basis. On average, equities analysts forecast that Henry Schein will post 5.17 earnings per share for the current year.
Henry Schein Company Profile
Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.
Featured Stories
- Five stocks we like better than Henry Schein
- How Technical Indicators Can Help You Find Oversold StocksĀ
- The Top 3 Sectors Poised For Growth This Summer
- Insider Trading – What You Need to Know
- U.S. Steel Stock: Betting on EPS Cut and Merger Uncertainty?
- The Role Economic Reports Play in a Successful Investment Strategy
- GitLab Stock: Pioneering the AI-Powered DevSecOps Platform
Receive News & Ratings for Henry Schein Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Henry Schein and related companies with MarketBeat.com's FREE daily email newsletter.